Fig. 4
From: B cells enhance IL-1 beta driven invasiveness in triple negative breast cancer
(a) CD20 And IL-1β expression in TN DCIS tissue sections. Immunohistochemical analysis of serial DCIS tissues from two patients showing CD20 (top, red) and IL-1β staining (bottom, red). Sections were counterstained with hematoxylin (blue). (b) CD20 and IL-1β expression in TNBC. Immunohistochemical analysis of serial sections of tumor from four TNBC patients showing CD20 (top, red) and IL-1β staining (bottom, red). Sections were counterstained with hematoxylin (blue).
